20/20 Biolabs Common Stock Overview

20/20 Biolabs Common Stock Selling, General & Admin

Selling, General & Admin expenses for AIDX.

Quarterly SG&A Expenses

$1.35M

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$4.75M

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin